홈 > 시장보고서 > 의약품 > 유전자 치료/RNAi

시장보고서

상품코드

1625460

mRNA 백신 및 치료제 시장 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 용도별, 치료 유형별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)

mRNA Vaccines and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Treatment Type, End User, and Region - Market Forecast, 2025-2034

발행일: 2024년 12월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 129 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, mRNA 백신 및 치료제 세계 시장 규모는 2034년까지 2,538억 3,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

mRNA 백신 및 치료제 시장은 특히 COVID-19 사태로 인해 빠르게 진화하고 있습니다. 메신저 RNA(mRNA) 기술은 COVID-19 백신 개발의 새로운 접근법으로 등장하여 전례 없는 속도와 유연성을 제공했습니다. 이 혁신은 팬데믹 상황에서 신속한 백신 생산의 길을 열었으며, 독감, 암, HIV 등 다양한 질병에 대한 미래 백신과 치료제에 대한 무한한 잠재력을 가지고 있습니다.

기존의 백신 개발은 최적의 항원을 찾아내고, 바이러스 샘플을 증식시키고, 대량의 백신을 생산하기 위해 종종 긴 과정을 거쳐야 했습니다. 반면, mRNA 기술은 병원체의 유전 암호를 빠르게 해독하고 필요한 항원을 암호화하는 mRNA를 합성할 수 있습니다. 즉, mRNA 백신은 유전자 서열만 알면 어떤 감염성 질환에 대해서도 즉시 개발이 가능하다는 뜻입니다. 이 능력으로 인해 독감이나 지카 바이러스 등 COVID-19 이외의 질병에 대한 mRNA 백신 연구가 진행되고 있습니다.

mRNA 치료제는 다른 용도, 특히 종양학에 대한 적용이 검토되고 있으며, Moderna와 BioNTech를 비롯한 여러 회사가 mRNA 기반 암 백신에 대한 임상시험을 시작했으며, 초기에는 유망한 결과를 얻었습니다. 이러한 백신은 단독으로 또는 화학요법이나 면역요법과 같은 다른 치료법과 함께 다양한 암 치료에 사용될 수 있습니다.

mRNA 백신 및 치료제 시장 보고서 하이라이트

용도별로는 mRNA 기술이 맞춤형 암 백신 및 암 면역 치료법 개발을 가능하게함으로써 암 치료에 혁명을 일으킬 수 있는 능력으로 인해 암 분야가 예측 기간 동안 급성장할 것으로 예상됩니다.

유형별로는 기존 비증폭형 mRNA 백신 부문이 2024년 mRNA 백신 및 치료제 시장 점유율을 독차지했으며, 그 효능이 입증되고 COVID-19 발생 시 널리 채택되었기 때문으로 분석됩니다.

세계 시장에서 북미는 탄탄한 헬스케어 인프라, R&D에 대한 막대한 투자, mRNA 기술의 급속한 발전으로 인해 2024년 북미가 가장 큰 매출 점유율을 차지했습니다.

세계 주요 시장 기업은 Pfizer Inc.; Moderna, Inc., BioNTech SE, GlaxoSmithKline, Daiichi Sankyo, BioNTech SE, CureVac N.V., AstraZeneca, Ethris, Sanofi, Arcturus Therapeutics, Innovac Therapeutics, Kernal Biologics, Pantherna Therapeutics, pHion Therapeutics, Recode Therapeutics, Rejuvenation Technologies, RNAimmune, Strand Therapeutics, Walvax, Ziphius Vaccines.입니다.

시장 현황
mRNA 백신 및 치료제 시장 역학
- 성장 촉진요인과 기회
  - 연구개발(R&D), 협업, 전략적 파트너십 확대
  - mRNA 기반 제품에 대한 규제 승인 증가
- 성장 억제요인과 과제
  - 엄격한 규제 기준
PESTEL 분석
mRNA 백신 및 치료제 시장 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 mRNA 백신 및 치료제 시장 : 유형별

주요 조사 결과
소개
자가 증폭형 mRNA 백신
기존 비증폭 mRNA 백신

제6장 세계의 mRNA 백신 및 치료제 시장 : 용도별

주요 조사 결과
소개
암
감염증
자가면역질환
기타

제7장 세계의 mRNA 백신 및 치료제 시장 : 치료 유형별

주요 조사 결과
소개
단클론항체
유전자 치료
세포 치료
기타

제8장 세계의 mRNA 백신 및 치료제 시장 : 최종사용자별

주요 조사 결과
소개
조사기관·연구기관
병원
클리닉
기타

제9장 세계의 mRNA 백신 및 치료제 시장 : 지역별

주요 조사 결과
소개
- mRNA 백신 및 치료제 시장 평가 : 지역, 2020-2034년
북미
- 북미 : 유형별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 북미 : 치료 유형별, 2020-2034년
- 북미 : 최종사용자별, 2020-2034년
- 미국
- 캐나다
유럽
- 유럽 : 유형별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 유럽 : 치료 유형별, 2020-2034년
- 유럽 : 최종사용자별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 유형별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 아시아태평양 : 치료 유형별, 2020-2034년
- 아시아태평양 : 최종사용자별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 중동 및 아프리카 : 치료 유형별, 2020-2034년
- 중동 및 아프리카 : 최종사용자별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 라틴아메리카 : 치료 유형별, 2020-2034년
- 라틴아메리카 : 최종사용자별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제10장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제11장 기업 개요

Pfizer Inc.
Moderna, Inc.
BioNTech SE
GlaxoSmithKline
Daiichi Sankyo
BioNTech SE
CureVac N.V.
AstraZeneca
Ethris
Sanofi
Arcturus Therapeutics
Innovac Therapeutics
Kernal Biologics
Pantherna Therapeutics
Ziphius Vaccines

ksm 25.02.06

The global mRNA vaccines and therapeutics market size is expected to reach USD 253.83 billion by 2034, according to a new study by Polaris Market Research. The report "mRNA Vaccines and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (Self-Amplifying mRNA-Based Vaccines and Conventional Non-Amplifying mRNA-Based Vaccines), Application, Treatment Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The mRNA vaccines and therapeutics market has seen a rapid evolution, particularly with the emergence of the COVID-19 outbreak. Messenger RNA (mRNA) technology emerged as an approach for COVID-19 vaccine development, offering unprecedented speed and flexibility. This innovation has created the way for rapid vaccine production during the pandemic and holds immense potential for future vaccines and therapeutics for a wide array of diseases such as influenza, cancer, and HIV.

Traditional vaccine development often requires lengthy processes to identify the most suitable antigens, grow virus samples, and produce large quantities of vaccine doses. In contrast, mRNA technology allows for rapid sequencing of a pathogen's genetic code, followed by the synthesis of mRNA that encodes the required antigen. This means that mRNA vaccines can be developed for any infectious disease as soon as its genetic sequence is known. This capability has prompted the exploration of mRNA vaccines for diseases beyond COVID-19, including influenza and Zika virus.

mRNA therapeutics are being explored for other applications, particularly in oncology. Several companies, including Moderna and BioNTech, have begun clinical trials for mRNA-based cancer vaccines, with promising early results. These vaccines may potentially be used to treat a variety of cancers, as standalone therapies or in combination with other treatments such as chemotherapy and immunotherapy.

mRNA Vaccines and Therapeutics Market Report Highlights

In terms of application, the cancer segment is expected to grow at a rapid pace during the forecast period owing to the ability of mRNA technology to revolutionize cancer treatment by enabling the development of personalized cancer vaccines and cancer immunotherapies.

Based on type, the conventional non-amplifying mRNA-based vaccines segment dominated the mRNA vaccines and therapeutics market share in 2024 owing to their proven efficacy and widespread adoption during the COVID-19 outbreak.

In the global market, North America held the largest revenue share in 2024 due to robust healthcare infrastructure, significant investments in research and development, and rapid advancements in mRNA technology.

A few of the global key market players are Pfizer Inc.; Moderna, Inc.; BioNTech SE; GlaxoSmithKline; Daiichi Sankyo; BioNTech SE; CureVac N.V.; AstraZeneca; Ethris; Sanofi; Arcturus Therapeutics; Innovac Therapeutics; Kernal Biologics; Pantherna Therapeutics; pHion Therapeutics; Recode Therapeutics; Rejuvenation Technologies; RNAimmune; Strand Therapeutics; Walvax; and Ziphius Vaccines.

Polaris Market Research has segmented the mRNA vaccines and therapeutics market report on the basis of type, application, treatment type, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Self-Amplifying mRNA-Based Vaccines
Conventional Non-Amplifying mRNA-Based Vaccines

By Application Outlook (Revenue, USD Billion, 2020-2034)

Cancer
Infectious Diseases
Autoimmune Diseases
Others

By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)

Monoclonal Antibody
Gene Therapy
Cell Therapy
Other

By End User Outlook (Revenue, USD Billion, 2020-2034)

Research Laboratories and Organizations
Hospitals
Clinics
Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global mRNA Vaccines and Therapeutics Market Insights

4.1. mRNA Vaccines and Therapeutics Market - Market Snapshot
4.2. mRNA Vaccines and Therapeutics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Research and Development (R&D), Collaborations, and Strategic Partnerships
  - 4.2.1.2. Increased Regulatory Approvals for mRNA-based Products
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Strict regulatory norms
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. mRNA Vaccines and Therapeutics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global mRNA Vaccines and Therapeutics Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
5.3. Self-amplifying mRNA-based Vaccines
- 5.3.1. Global mRNA Vaccines and Therapeutics Market, by Self-amplifying mRNA-based Vaccines, by Region, 2020-2034 (USD Billion)
5.4. Conventional Non-amplifying mRNA-based Vaccines
- 5.4.1. Global mRNA Vaccines and Therapeutics Market, by Conventional Non-amplifying mRNA-based Vaccines, by Region, 2020-2034 (USD Billion)

6. Global mRNA Vaccines and Therapeutics Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
6.3. Cancer
- 6.3.1. Global mRNA Vaccines and Therapeutics Market, by Cancer, by Region, 2020-2034 (USD Billion)
6.4. Infectious Diseases
- 6.4.1. Global mRNA Vaccines and Therapeutics Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
6.5. Autoimmune Diseases
- 6.5.1. Global mRNA Vaccines and Therapeutics Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
6.6. Others
- 6.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global mRNA Vaccines and Therapeutics Market, by Treatment Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
7.3. Monoclonal Antibody
- 7.3.1. Global mRNA Vaccines and Therapeutics Market, by Monoclonal Antibody, by Region, 2020-2034 (USD Billion)
7.4. Gene Therapy
- 7.4.1. Global mRNA Vaccines and Therapeutics Market, by Gene Therapy, by Region, 2020-2034 (USD Billion)
7.5. Cell Therapy
- 7.5.1. Global mRNA Vaccines and Therapeutics Market, by Cell Therapy, by Region, 2020-2034 (USD Billion)
7.6. Others
- 7.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global mRNA Vaccines and Therapeutics Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
8.3. Research Laboratories and Organizations
- 8.3.1. Global mRNA Vaccines and Therapeutics Market, by Research Laboratories and Organizations, by Region, 2020-2034 (USD Billion)
8.4. Hospitals
- 8.4.1. Global mRNA Vaccines and Therapeutics Market, by Hospitals, by Region, 2020-2034 (USD Billion)
8.5. Clinics
- 8.5.1. Global mRNA Vaccines and Therapeutics Market, by Clinics, by Region, 2020-2034 (USD Billion)
8.6. Others
- 8.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global mRNA Vaccines and Therapeutics Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. mRNA Vaccines and Therapeutics Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. mRNA Vaccines and Therapeutics Market - North America
- 9.3.1. North America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 9.3.2. North America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 9.3.3. North America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
- 9.3.4. North America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.3.5. mRNA Vaccines and Therapeutics Market - US
  - 9.3.5.1. US: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.3.5.2. US: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.3.5.3. US: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.3.5.4. US: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.3.6. mRNA Vaccines and Therapeutics Market - Canada
  - 9.3.6.1. Canada: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
9.4. mRNA Vaccines and Therapeutics Market - Europe
- 9.4.1. Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 9.4.3. Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
- 9.4.4. Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.5. mRNA Vaccines and Therapeutics Market - UK
  - 9.4.5.1. UK: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.6. mRNA Vaccines and Therapeutics Market - France
  - 9.4.6.1. France: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.6.3. France: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.6.4. France: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.7. mRNA Vaccines and Therapeutics Market - Germany
  - 9.4.7.1. Germany: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.8. mRNA Vaccines and Therapeutics Market - Italy
  - 9.4.8.1. Italy: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.9. mRNA Vaccines and Therapeutics Market - Spain
  - 9.4.9.1. Spain: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.10. mRNA Vaccines and Therapeutics Market - Netherlands
  - 9.4.10.1. Netherlands: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.11. mRNA Vaccines and Therapeutics Market - Russia
  - 9.4.11.1. Russia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.12. mRNA Vaccines and Therapeutics Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
9.5. mRNA Vaccines and Therapeutics Market - Asia Pacific
- 9.5.1. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.5. mRNA Vaccines and Therapeutics Market - China
  - 9.5.5.1. China: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.5.3. China: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.5.4. China: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.6. mRNA Vaccines and Therapeutics Market - India
  - 9.5.6.1. India: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.6.3. India: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.6.4. India: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.7. mRNA Vaccines and Therapeutics Market - Malaysia
  - 9.5.7.1. Malaysia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.8. mRNA Vaccines and Therapeutics Market - Japan
  - 9.5.8.1. Japan: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.9. mRNA Vaccines and Therapeutics Market - Indonesia
  - 9.5.9.1. Indonesia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.10. mRNA Vaccines and Therapeutics Market - South Korea
  - 9.5.10.1. South Korea: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.11. mRNA Vaccines and Therapeutics Market - Australia
  - 9.5.11.1. Australia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.12. mRNA Vaccines and Therapeutics Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
9.6. mRNA Vaccines and Therapeutics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.6.5. mRNA Vaccines and Therapeutics Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.6.6. mRNA Vaccines and Therapeutics Market - UAE
  - 9.6.6.1. UAE: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.6.7. mRNA Vaccines and Therapeutics Market - Israel
  - 9.6.7.1. Israel: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.6.8. mRNA Vaccines and Therapeutics Market - South Africa
  - 9.6.8.1. South Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.6.9. mRNA Vaccines and Therapeutics Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
9.7. mRNA Vaccines and Therapeutics Market - Latin America
- 9.7.1. Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 9.7.3. Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
- 9.7.4. Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.7.5. mRNA Vaccines and Therapeutics Market - Mexico
  - 9.7.5.1. Mexico: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.7.6. mRNA Vaccines and Therapeutics Market - Brazil
  - 9.7.6.1. Brazil: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.7.7. mRNA Vaccines and Therapeutics Market - Argentina
  - 9.7.7.1. Argentina: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.7.8. mRNA Vaccines and Therapeutics Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Pfizer Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Moderna, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. BioNTech SE
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. GlaxoSmithKline
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Daiichi Sankyo
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. BioNTech SE
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. CureVac N.V.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. AstraZeneca
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Ethris
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Sanofi
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Arcturus Therapeutics
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Innovac Therapeutics
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Kernal Biologics
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Pantherna Therapeutics
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. Ziphius Vaccines
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,250

￦ 6,149,000

PDF (Multi User License)

PDF 보고서를 동일 기업 20명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,250

￦ 7,596,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250

￦ 9,043,000

※ 부가세 별도